ES2115683T3 - Inmunoensayo indirecto para detectar compuestos de tipo dioxina. - Google Patents

Inmunoensayo indirecto para detectar compuestos de tipo dioxina.

Info

Publication number
ES2115683T3
ES2115683T3 ES92925178T ES92925178T ES2115683T3 ES 2115683 T3 ES2115683 T3 ES 2115683T3 ES 92925178 T ES92925178 T ES 92925178T ES 92925178 T ES92925178 T ES 92925178T ES 2115683 T3 ES2115683 T3 ES 2115683T3
Authority
ES
Spain
Prior art keywords
dioxin
type compounds
immuno assay
indirect immuno
phosphorilation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92925178T
Other languages
English (en)
Inventor
John G Babish
Sakina El-Tom
Xinfang Ma
Geoffrey Wheelock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of ES2115683T3 publication Critical patent/ES2115683T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/40—Dioxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

ESTA INVENCION ES RELATIVA A LA DETERMINACION DE EXPOSICION EN VIVO A COMPUESTOS DE TIPO DIOXINA Y A LA CUANTIFICACION IN VITRO DE COMPUESTOS TIPO DIOXINA BASADOS EN LA FOSFORILACION DE TIROSINA DE PROTEINA INTERMEDIA POR EL RECEPTOR AH. LA AMPLITUD DE FOSFORILACION DE TIROSINA DE PROTEINA SE DETERMINA POR ANTICUERPOS MONOCLONALES PARA EL FOSFATO DE TIROSINA DE LA PROTEINA. LA CANTIDAD Y NATURALEZA DE TIROSILFOSFATOS DE LA PROTEINA ESTA CUANTITATIVAMENTE RELACIONADA A LA CONCENTRACION EN VIVO O IN VITRO DE DIOXINA A LA CUAL ESTAN EXPUESTOS CELULAS O ANIMALES. ESTE METODO PERMITE DETECCION DE COMPUESTOS DE TIPO DIOXINA A CONCENTRACIONES EN EL RANGO DE PARTES POR BILLON Y PARTES POR MIL MILLONES.
ES92925178T 1991-11-15 1992-11-13 Inmunoensayo indirecto para detectar compuestos de tipo dioxina. Expired - Lifetime ES2115683T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79292291A 1991-11-15 1991-11-15
US79519391A 1991-11-19 1991-11-19

Publications (1)

Publication Number Publication Date
ES2115683T3 true ES2115683T3 (es) 1998-07-01

Family

ID=27121346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92925178T Expired - Lifetime ES2115683T3 (es) 1991-11-15 1992-11-13 Inmunoensayo indirecto para detectar compuestos de tipo dioxina.

Country Status (7)

Country Link
US (2) US5529899A (es)
EP (1) EP0614530B1 (es)
JP (1) JP3253300B2 (es)
DE (1) DE69224651T2 (es)
DK (1) DK0614530T3 (es)
ES (1) ES2115683T3 (es)
WO (1) WO1993010460A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127136A (en) * 1995-10-23 2000-10-03 Paracelsian, Inc. Detection of dioxin-like compounds by detection of transformed Ah receptor/ARNT complex
US5800784A (en) 1996-07-09 1998-09-01 Horn; Marcus J. Chemical sample treatment system and cassette, and methods for effecting multistep treatment process
ES2302349T3 (es) 1997-03-07 2008-07-01 Disc-O-Tech Medical Technologies, Ltd. Sistemas para la estabilizacion, fijacion y reparacion osea y vertebral percutaneas.
US5854010A (en) * 1997-03-10 1998-12-29 Denison; Michael S. Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor
US20030044856A1 (en) * 1997-09-26 2003-03-06 Puschett Jules B. Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus
WO1999045390A1 (en) * 1998-03-03 1999-09-10 Frank Comhaire Composition and device for the detection and elimination of endocrine hormones and/or hormone disrupting substances in and from fluids
DE19811327A1 (de) * 1998-03-16 1999-09-30 Karlsruhe Forschzent Verfahren zur Bestimmung von chemischen Verbindungen
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
AU6487899A (en) * 1998-10-30 2000-05-22 Takara Shuzo Co., Ltd. Method for detecting gene affected by endocrine disruptor
US6309828B1 (en) 1998-11-18 2001-10-30 Agilent Technologies, Inc. Method and apparatus for fabricating replicate arrays of nucleic acid molecules
EP1258726B1 (en) * 2000-01-20 2007-06-20 Kyowa Hakko Kogyo Co., Ltd. Method of detecting or quantifying environmental hormones
EP2289550A3 (en) * 2000-01-27 2012-02-15 MedImmune, LLC Ultra high affinity neutralizing antibodies
DK1259547T3 (da) * 2000-03-01 2012-10-15 Medimmune Inc Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) * 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
WO2003023380A1 (en) 2001-09-10 2003-03-20 Meso Scale Technologies, Llc Assay buffer, compositions containing the same, and methods of using the same
WO2004001371A2 (en) * 2001-11-02 2003-12-31 Hybrizyme Corporation Receptor capture assay
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US20050244953A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Techniques for controlling the optical properties of assay devices
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
US20080237458A1 (en) * 2007-04-02 2008-10-02 Yongdong Wang Automated mass spectral identification
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
US8877434B2 (en) 2012-04-19 2014-11-04 Hsinyu Lee Method and system of detecting dioxin-like compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238472A (en) * 1978-11-27 1980-12-09 United States Of America Radioimmunoassay for chlorinated dibenzo-p-dioxins
US4904595A (en) * 1985-06-14 1990-02-27 Health Research Incorporated Epithelial cell line useful in the detection of dioxinlike compounds and methods of making and using same
US4798807A (en) * 1986-06-24 1989-01-17 The Regents Of The University Of California Monoclonal antibodies and method for detecting dioxins and dibenzofurans
US4891322A (en) * 1987-02-24 1990-01-02 Mobil Oil Corporation Assaying of polynuclear aromatic compounds
NL8900529A (nl) * 1989-03-03 1990-10-01 Eurodiagnostics B V Werkwijze en kit voor het bepalen van tyrosine fosforylerende en defosforylerende activiteit.
US5262297A (en) * 1990-06-18 1993-11-16 Eastman Kodak Company Specific binding analytical and separation methods using carboxy containing polymers
IL102523A0 (en) * 1991-07-31 1993-01-14 Du Pont Enhancing the chemiluminescence of enzyme-triggered 1,2-dioxetanes

Also Published As

Publication number Publication date
DE69224651T2 (de) 1998-07-23
EP0614530B1 (en) 1998-03-04
US5496703A (en) 1996-03-05
DK0614530T3 (da) 1998-09-28
JP3253300B2 (ja) 2002-02-04
WO1993010460A1 (en) 1993-05-27
EP0614530A4 (en) 1995-06-07
DE69224651D1 (de) 1998-04-09
EP0614530A1 (en) 1994-09-14
US5529899A (en) 1996-06-25
JPH07501883A (ja) 1995-02-23

Similar Documents

Publication Publication Date Title
ES2115683T3 (es) Inmunoensayo indirecto para detectar compuestos de tipo dioxina.
Gillespie et al. Chemiluminescence detection of proteins from single cells.
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
Galgani et al. Interaction of environmental xenobiotics with a multixenobiotic defense mechanism in the bay mussel Mytilus galloprovincialis from the coast of California
ES2274514T5 (es) Eotaxina = citocina quimiotáctica de eosinófilos
ES2077863T3 (es) Deteccion de necrosis celular por medio de analisis de deteccion de la espectrina y de los productos de descomposicion de esta ultima.
ES2093017T3 (es) Anticuerpo contra el receptor de la interleuquina-6 humana.
FR2595817B1 (fr) Procede de determination de l'orientation d'une plate-forme de capteur imageur ou instrument analogue
PT848755E (pt) Proteina relacionada com o vegf
Kashikar et al. Temporal sampling, resetting, and adaptation orchestrate gradient sensing in sperm
DE3687490D1 (de) Remissionsmessgeraet zur beruehrungslosen messung.
ATE196010T1 (de) Zusammensetzung zur kalibrierung oder kontrolle zur verwendung in einem serologischen igm-test
ES2133772T3 (es) Inmunoensayo para la homocisteina.
ATE275728T1 (de) Verfahren und biosensor zum nachweis von antigenen
López-Unzu et al. Differential expression of myosin heavy chain isoforms in cardiac segments of gnathostome vertebrates and its evolutionary implications
ES2235479T3 (es) Analisis inmunologico de la cromogranina a (cga) humana, anticuerpos, reactivos y kits para dicho analisis.
WO2013110837A1 (es) Haptenos, conjugados y anticuerpos para el fungicida pirimetanil
Ara et al. Dot‐Elisa for the rapid detection of gentamicin in milk
Gönenç et al. Comparison of crude and excretory/secretory antigens for the diagnosis of Fasciola hepatica in sheep by western blotting
DK1423543T3 (da) Detektion af bovin virusdiarré-virus i vævspröver
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
KR930000539A (ko) 신규항 tcf-ii 모노클로날 항체 및 그것을 사용한 tcf-ii 측정방법
Peniston‐Bird et al. An enzyme immunoassay for 6‐sulphatoxy‐melatonin in human urine
ITRM920603A1 (it) La sequenza dell'inserto cprl3, parte del gene della proteina della oociste di cryptosporidium (cowp), e derivati utili per la diagnosi dell'infezione da cryptosporidium
Pacheco-Tovar et al. Associated autoimmunity and lead exposure in childhood

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614530

Country of ref document: ES